Acrigen Biosciences is an early-stage life science gene-editing company based in Berkeley, California. They are building a pipeline of therapies to treat genetic disorders using their proprietary precision gene-editing technology.

Biotechnology

Acrigen Biosciences

Acrigen Biosciences' headquarters in Berkeley, CA, United States

David Rabuka

Trevor Collingwood

Joseph Bondy-Denomy

Heath Lukatch

Alan Davidson

Tippi Mackenzie

Ben Kleinstiver

David Schaffer

Karen Boezi

The Leadership Team at Acrigen Biosciences guides the strategic direction and operational execution of the company's gene-editing initiatives. Comprised of seasoned experts, including the CEO and Chief Technology Officer, this team oversees research priorities, technology development, and collaboration with scientific advisory boards to drive innovation and navigate the pathway to commercialization of cutting-edge therapies for genetic disorders.

Leadership Team

The Scientific Advisory Board at Acrigen Biosciences provides expert guidance on the company's gene-editing technologies, advises on research and development strategies, and helps navigate regulatory and ethical considerations in the pursuit of therapies for genetic disorders.

Acrigen Biosciences

Org chart

Board & advisors

Teams

Leadership Team

Scientific Advisory Board

Offices

Acrigen Biosciences

Org chart

Board & advisors

Teams

Leadership Team

Scientific Advisory Board

Offices

Related companies